APDS is a rare inherited immune condition that has been reported in less than 300 people worldwide. So how could studying it help improve outcomes for the millions of people who live with autoimmune disease? Today, we meet A/Prof Elissa Deenick, a researcher who is taking a deep dive into the genetics of immune cells to make sure no patient gets left behind.

Support Garvan research: https://www.garvan.org.au/support-us/give-now

See omnystudio.com/listener for privacy information.